• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Study: Accurate refractive predictions remain difficult in patients with keratoconus

Video

Newer generation formulas generally outperformed older generation formulas, with SRK/T performing the best of older formulas, especially when using TK values.

Presented by Michael Heath, the study, “Comparison of Keratometry vs. Total Keratometry with Multivariable IOL Formulas Keratoconic Eyes," showed that accurate refractive predictions remain difficult in patients with keratoconus, and if TK is available, surgeons should use it in patients with keratoconus regardless of formula.

Purpose:

  • Biometry is difficult in eyes with keratoconus
  • Assumptions made about the posterior cornea don’t hold true in keratoconus
  • TK may provide better predictions in eyes with keratoconus due to direct measurements of the anterior and posterior corneal surface

Discussion:

  • Barrett KCN-measured performed the best, with Barrett KCN-predicted performing second best
  • Kane KCN-predicted K was not statistically worse than Barrett KCN (measured and predicted)
  • The TK version of every formula outperformed the respective K version
  • Newer generation formulas generally outperformed older generation formulas, with SRK/T performing the best of older formulas, especially when using TK values

Conclusion:

  • Accurate refractive predictions remain difficult in patients with keratoconus
  • If TK is available, surgeons should use it in patients with keratoconus regardless of formula
  • KCN-specific formulas (Kane KCN and Barrett KCN, both measured and predicted) should be used whenever possible
Related Videos
Dr. Neda Nikpoor Shares Practical Techniques to Combat Unconscious Gender Bias and Promote Gender Equality in Ophthalmology
ASCRS 2024: George O. Waring, MD, shares early clinical performance of bilateral Odyssey implantation
ASCRS 2024: Deborah Gess Ristvedt, DO, discusses third-generation trabecular micro-bypass
Arjan Hura, MD, highlights the clinical and surgical updates at CIME 2024
© 2024 MJH Life Sciences

All rights reserved.